Please login to the form below

Not currently logged in
Email:
Password:

Pharma news in brief

Our weekly round-up of the news in brief

EU should get tough on counterfeits
Tougher measures must be introduced in the European Union to stamp out trading of counterfeit drugs, according to a new report from Professor David Taylor from the University of London School of Pharmacy. Professor Taylor said that while the problem had originally been concentrated in developing countries, the global nature of the pharma industry means that patients everywhere are now at risk. In his report, which was launched at the House of Commons on November 29, he noted that the increased rationing of drugs could fuel the practice of counterfeiting. He has called for tougher legal penalties and better control of internet pharmacies, suggesting that because parallel trade, while not illegal, is difficult to monitor, it is attractive to counterfeiters. The report was funded by a grant from Pfizer.

HIV/AIDS drugs should be available in the workplace
The International Labour Organisation, part of the United Nations, has said that the workplace could offer the best setting to administer anti-retroviral (ARVs) drugs to people with HIV/AIDS. In a report published on World AIDS Day, the agency said that more than 24 million people in the global workforce in 2005 had HIV/AIDS, with 67 per cent living in Africa. The agency believes that ARVs should be made available in the workplace, estimating that 1.8 million more Africans could be alive in 2010 if 80 per cent of the workforce were treated with them.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics